Recursion的动态

查看Recursion的组织主页

60,379 位关注者

Today we announced a collaboration and $50 million investment from NVIDIA to accelerate our groundbreaking foundation models in AI-enabled drug discovery. Read the press release: https://lnkd.in/gXVpntt2 Read the blog from our CTO Ben Mabey: https://lnkd.in/gdCB3U-v #nvidia #drugdiscovery #techbio #ai #biotech

  • graphical user interface, text
Jeff Scott

Senior Strategic Account Manager - Do'er Helping Companies Achieve and Maintain Excellence in The Cloud.

1 年

Extremely well deserved partnership opportunity for Recursion. I'm excited to see all the new innovation that grows from this partnership.

回复

Very cool. Well done Tina.

Jim Morgan

Data Engineer | Bridging the physical, computational, and data sciences

1 年

I was wondering why the stock price jumped so high. This makes sense now.

回复
Michael J. Murphy

Associate Wealth Consultant ~Stockbroking, Financial Advice QFA LIB EFA AFP

1 年

Congrats ?? #Ai #Drugresearch #innovation

回复
Rick Panicucci

Chief Technology Officer of CMC at BridgeBio

1 年

very exciting for the drug discovery field

It was a great privilege getting to work with the entire Recursion team on this transaction. Here's to a very productive collaboration between us!

回复
Charlene Liao

CEO and Board Chair of Immune-Onc Therapeutics, Inc.

1 年

Congratulations Tina Marriott Larson

Ben Toney, MBA, CSCP

Business Analyst & Supply Chain Project Manager | MBA, CSCP

1 年

This sounds like a powerful and exciting partnership!

回复

Very nice, congrats.

回复

Terrific news

回复
查看更多评论

要查看或添加评论,请登录